{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:56:54Z","timestamp":1781639814850,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100022752","name":"MSD Sharp and Dohme","doi-asserted-by":"publisher","award":["Investigator-Initiated Studies Program"],"award-info":[{"award-number":["Investigator-Initiated Studies Program"]}],"id":[{"id":"10.13039\/100022752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Canc Educ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In 2019, the U.S. Advisory Committee on Immunization Practices recommended shared clinical decision-making (SCDM) for HPV vaccination among unvaccinated adults aged 27\u201345 years (i.e., mid-adult). However, the implementation of this recommendation is challenging. This study assessed a decision tool, HPV Decide, designed to facilitate SCDM for mid-adult HPV vaccination. We used exploratory sequential mixed methods to gather stakeholder and provider perspectives on a beta version of HPV Decide. Qualitative feedback from providers and stakeholders (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200924) was collected through semi-structured interviews. Quantitative data from health care providers (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u2009600) on usability in clinical practice was collected via online surveys. Interviewees provided feedback on the preferred delivery method and timing, the need for support and training, and key barriers and facilitators to SCDM. Quantitative data showed that 68.3% of providers were likely to use the tool, 67% believed it could be easily integrated into practice, and 54% thought patients would be interested in using it. Findings suggest that a web-based decision tool to facilitate SCDM for mid-adult HPV vaccination is both acceptable and feasible for integration into clinical practice. Providers expressed strong preferences for clinic-based access and electronic delivery. Clinicians supported the integration of a web-based decision tools into clinical practice to enhance shared decision-making.\n                  <\/jats:p>","DOI":"10.1007\/s13187-026-02847-8","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:25:22Z","timestamp":1773026722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinician Perspectives on the Implementation of a Web-Based Tool to Support Shared Decision-Making for Mid-Adult HPV Vaccination"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0452-0252","authenticated-orcid":false,"given":"Christopher W.","family":"Wheldon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Alkhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idara N.","family":"Akpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Zimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Luningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika L.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2847_CR1","unstructured":"CDC (2023) Cancers associated with human papillomavirus, United States \u2014 2012\u20132016. https:\/\/www.cdc.gov\/cancer\/uscs\/about\/data-briefs\/no10-hpv-assoc-cancers-UnitedStates-2012-2016.htm. Accessed 31 May 2024"},{"key":"2847_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura EA, Giuliano AR, Iversen O-E et al (2015) A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 372:711\u2013723. https:\/\/doi.org\/10.1056\/NEJMoa1405044","journal-title":"N Engl J Med"},{"key":"2847_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.15585\/mmwr.mm6549a5","volume":"68","author":"E Meites","year":"2019","unstructured":"Meites E, Szilagyi PG, Chesson HW et al (2019) Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep 68:698\u2013702. https:\/\/doi.org\/10.15585\/mmwr.mm6549a5","journal-title":"Morb Mortal Wkly Rep"},{"key":"2847_CR4","volume-title":"Prescribing information [package insert]. Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant)","author":"Food and Drug Administration","year":"2018","unstructured":"Food and drug administration (2018) Prescribing information [package insert]. Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant). US department of health and human services, food and drug adiminstration, Silver Spring, MD"},{"key":"2847_CR5","doi-asserted-by":"publisher","first-page":"107951","DOI":"10.1016\/j.ypmed.2024.107951","volume":"182","author":"IN Akpan","year":"2024","unstructured":"Akpan IN, Taskin T, Wheldon CW et al (2024) Human papillomavirus vaccination uptake among 27-to-45-year-olds in the United States. Prev Med 182:107951. https:\/\/doi.org\/10.1016\/j.ypmed.2024.107951","journal-title":"Prev Med"},{"key":"2847_CR6","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.vaccine.2023.02.051","volume":"41","author":"CA Gidengil","year":"2023","unstructured":"Gidengil CA, Parker AM, Markowitz LE et al (2023) Health care provider knowledge around shared clinical decision-making regarding HPV vaccination of adults aged 27\u201345 years in the United States. Vaccine 41:2650\u20132655. https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.051","journal-title":"Vaccine"},{"key":"2847_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3122\/jabfm.2021.01.200408","volume":"34","author":"LP Hurley","year":"2021","unstructured":"Hurley LP, O\u2019Leary ST, Markowitz LE et al (2021) US primary care physicians\u2019 viewpoints on HPV vaccination for adults 27 to 45 years. J Am Board Fam Med 34:162\u2013170. https:\/\/doi.org\/10.3122\/jabfm.2021.01.200408","journal-title":"J Am Board Fam Med"},{"key":"2847_CR8","doi-asserted-by":"publisher","first-page":"ofad004","DOI":"10.1093\/ofid\/ofad004","volume":"10","author":"LM King","year":"2023","unstructured":"King LM, Lewnard JA, Niccolai LM (2023) Clinical and public health considerations for HPV vaccination in mid adulthood: a narrative review. Open Forum Infect Dis 10:ofad004. https:\/\/doi.org\/10.1093\/ofid\/ofad004","journal-title":"Open Forum Infect Dis"},{"key":"2847_CR9","unstructured":"Chesson H (2019) Overview of health economic. Models for HPV vaccination of mid-adults"},{"key":"2847_CR10","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1080\/21645515.2020.1852870","volume":"17","author":"V Daniels","year":"2021","unstructured":"Daniels V, Prabhu VS, Palmer C et al (2021) Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States. Hum Vaccines Immunotherapeutics 17:1943\u20131951. https:\/\/doi.org\/10.1080\/21645515.2020.1852870","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"2847_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD001431.pub5","volume":"CD001431","author":"D Stacey","year":"2017","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Reviews CD001431:1\u2013242. https:\/\/doi.org\/10.1002\/14651858.CD001431.pub5","journal-title":"Cochrane Database Syst Reviews"},{"key":"2847_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/0272989X20936209","volume":"40","author":"L Hoefel","year":"2020","unstructured":"Hoefel L, O\u2019Connor AM, Lewis KB et al (2020) 20th anniversary update of the ottawa decision support framework part 1: a systematic review of the decisional needs of people making health or socialdecisions. Med Decis Mak 40:555\u2013581. https:\/\/doi.org\/10.1177\/0272989X20936209","journal-title":"Med Decis Mak"},{"key":"2847_CR13","unstructured":"Wheldon CW, Akpan IN, Taskin T et al (2023) HPV decide: the development of a comprehensive tool for facilitating informed HPV vaccination choices among adults aged 27 to 45"},{"key":"2847_CR14","unstructured":"The Ottawa Hospital (2024) HPV vaccine decide. In: patient decision aids research group. https:\/\/decisionaid.ohri.ca\/AZsumm.php?ID=2087. Accessed 7 Oct 2024"},{"key":"2847_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE et al (2009) Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 4:1\u201315. https:\/\/doi.org\/10.1186\/1748-5908-4-50","journal-title":"Implement Sci"},{"key":"2847_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/0272989X20924645","volume":"40","author":"L Hoefel","year":"2020","unstructured":"Hoefel L, Lewis KB, O\u2019Connor A, Stacey D (2020) 20th anniversary update of the ottawa decision support framework: part 2 subanalysis of a systematic review of patient decision aids. Med Decis Mak 40:522\u2013539. https:\/\/doi.org\/10.1177\/0272989X20924645","journal-title":"Med Decis Mak"},{"key":"2847_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/bmjqs-2018-008022","volume":"28","author":"CC Dobler","year":"2019","unstructured":"Dobler CC, Sanchez M, Gionfriddo MR et al (2019) Impact of decision aids used during clinical encounters on clinician outcomes and consultation length: a systematic review. BMJ Qual Saf 28:499\u2013510. https:\/\/doi.org\/10.1136\/bmjqs-2018-008022","journal-title":"BMJ Qual Saf"},{"key":"2847_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/0272989X15618175","volume":"36","author":"J Inselman","year":"2016","unstructured":"Inselman J, Branda M, Castaneda-Guarderas A et al (2016) Uptake and documentation of the use of an encounter decision aid in usual practice: a retrospective analysis of the use of the statin\/aspirin choice decision aid. Med Decis Mak 36:557\u2013561. https:\/\/doi.org\/10.1177\/0272989X15618175","journal-title":"Med Decis Mak"},{"key":"2847_CR19","doi-asserted-by":"publisher","first-page":"e22766","DOI":"10.2196\/22766","volume":"23","author":"P Scalia","year":"2021","unstructured":"Scalia P, Ahmad F, Schubbe D et al (2021) Integrating option grid patient decision aids in the epic electronic health record: case ctudy at 5 health systems. J Med Internet Res 23:e22766. https:\/\/doi.org\/10.2196\/22766","journal-title":"J Med Internet Res"}],"container-title":["Journal of Cancer Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-026-02847-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13187-026-02847-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-026-02847-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:36:00Z","timestamp":1781638560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13187-026-02847-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":19,"alternative-id":["2847"],"URL":"https:\/\/doi.org\/10.1007\/s13187-026-02847-8","relation":{},"ISSN":["0885-8195","1543-0154"],"issn-type":[{"value":"0885-8195","type":"print"},{"value":"1543-0154","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Dr.Thompson is a paid consultant for Merck for work on HPV vaccination. Dr. Zimet has receivedconsulting fees from Merck for work on HPV vaccination, has served on external advisorycommittees for Moderna (COVID-19 vaccination) and Pfizer (meningococcal vaccination), and has received investigator-initiated grant funding from Merck administered through Indiana University. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}